Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methocarbamol for prevention of succinylcholine-induced muscle fasciculation
IRCT2014061518099N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methocarbamol in fasciculation, sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Incidence of succinylcholine-induced muscle fasciculation. Started Mar 2012; status: completed.
02
Drugs
methocarbamol
03
Conditions
fasciculation
Beyond the preview
Go deeper on IRCT2014061518099N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014061518099N1.